A milestone for InVivo, as first patient is implanted with experimental scaffold

An Arizona surgeon is reporting that the first-ever implementation of an experimental treatment for acute spinal cord injury developed by InVivo Therapeutics went smoothly, sending shares of the Cambridge biotech soaring...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.